Premium
P98: Dose‐response and optimal administration timing of a new anti‐IL‐1 therapeutic, rytvela, for prevention of preterm birth and fetal injury
Publication year - 2021
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/aji.96_13420
Subject(s) - medicine , administration (probate law) , fetus , obstetrics , anesthesia , pregnancy , pharmacology , biology , political science , law , genetics